Trial record 1 of 1 for:
NCT05814536
IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05814536 |
|
Recruitment Status :
Recruiting
First Posted : April 18, 2023
Last Update Posted : December 14, 2023
|
Sponsor:
AnHeart Therapeutics Inc.
Information provided by (Responsible Party):
AnHeart Therapeutics Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | August 2025 |
| Estimated Study Completion Date : | May 2026 |